Latest Class Actions News

The Star Entertainment Group narrowed its net loss to $307 million in FY26, boosted by refinancing, operational improvements, and a joint venture exit, while navigating ongoing regulatory scrutiny and remediation efforts.

Shine Justice Ltd reported a modest 2.3% revenue increase to $209.2 million for FY26, alongside a striking 1,578% jump in net profit after tax to $9.6 million. The company declared a fully franked final dividend of 2.5 cents per share, signalling confidence amid ongoing investments in technology and international expansion.

Dubber Corporation Limited (ASX:DUB) posted a 17% revenue drop in FY26 to $35.1 million, mainly due to a major contract loss in Europe, but narrowed its net loss by 78% excluding impairments and achieved cash flow breakeven in H2.

Credit Clear Limited posted a 28% rise in FY26 revenue to $60 million, boosted by UK acquisitions and organic growth, while defending legal action by the ACCC.

Domino’s Pizza Enterprises reported a $134.2 million statutory loss for FY26 due to significant non-cash impairments, while underlying profit rose 4%. The company is closing up to 60 stores and focusing on franchisee profitability and cost reductions.

Lovisa Holdings reported a robust FY26 with revenue up 17.6% to A$938.8 million, expanded its global store network to 1,136 locations, and declared a 33 cent final dividend, reflecting strong momentum in key markets.

Shine Justice Ltd has taken a $13 million write down on a longstanding class action after an unexpected interlocutory judgment, cutting FY26 profit but leaving cash flow unaffected. Management plans to appeal and maintains confidence in the claim’s merits.

Arena REIT reported an 8% rise in net operating profit to $79.1 million for FY2026, driven by rental growth and development completions, while facing uncertainty over its Edge Early Learning Portfolio due to rent defaults.

Ovanti Limited has announced a complete global exit from the Buy Now Pay Later sector, ceasing all BNPL activities and shifting its focus to its established iSentric business in Southeast Asia, alongside significant cost reductions and imminent legal action against its former US BNPL CEO.

Telix Pharmaceuticals returned to profit in H1 2026, driven by strong U.S. sales of Illuccix and Gozellix, a $40 million upfront from Regeneron collaboration, and expanded R&D investment.

Brambles Limited posted a 6% rise in sales revenue to US$7.04 billion for FY26, navigating US repair bottlenecks with decisive investments and reaffirming growth targets for FY27 and beyond.

Medibank Private Limited reported a 27.5% jump in net profit after tax to $638.7 million for FY26, driven by steady health insurance growth and a 31.3% surge in its Medibank Health segment. The company declared a fully franked final dividend of 10.9 cents per share and updated its Net Zero emissions strategy.